Cancer is not only a genetic disease but also influenced by physical forces and the mechanical properties of cells and tissues. Understanding how these forces impact tumor growth, metastasis, and drug resistance has opened new avenues for cancer research. The Cancer Engineering R&D Core Facility provides researchers with cutting-edge microfabrication and 3D printing technologies, allowing the development of experimental models and diagnostic tools that bridge fundamental research and clinical applications.
The Cancer Engineering R&D Core Facility at IFOM develops innovative biomedical technologies and devices to advance cancer research and biomedical applications. By integrating expertise from biology, physics, engineering, and material science, the facility creates state-of-the-art tools to study the mechanical properties of cancer cells, tumor progression, and therapeutic responses.
The Cancer Engineering R&D Core Facility supports a wide range of research projects, focusing on the development and application of advanced biomedical technologies. Key areas include:
The Cancer Engineering R&D Core Facility collaborates with leading IFOM research groups, applying state-of-the-art engineering solutions to fundamental and translational cancer research.
The Cancer Engineering R&D Core Facility is equipped with advanced technologies for microfabrication, 3D printing, cell biomechanics, and the preparation of microstructured devices and surfaces. Below is a list of the main equipment available:
Cell stretching dish, European Patent application n. PCT/EP2018/053477, 2017
Cell compression device, European Patent application n. EP172000564, 2018
Qingsen Li is a multidisciplinary scientist with expertise in mechanical engineering, bioengineering, and mechanobiology. Since 2018, he has led the Cancer Engineering R&D Core Facility at IFOM, where he develops cutting-edge biomedical technologies for cancer research and clinical applications. After earning his degree in Engineering Mechanics from Huazhong University of Science and Technology in 2003, Qingsen pursued his master’s research in computational simulation for bridge design. However, his growing interest in biology led him to the National University of Singapore, where he obtained a PhD in Bioengineering in 2010 under Prof. Chwee Teck Lim. His doctoral work provided groundbreaking insights into cancer cell mechanics, showing that breast cancer cells are softer than normal cells. He also developed microfluidic devices for high-throughput cancer cell detection. Qingsen then joined the Mechanobiology Institute in Singapore, where his research focused on how cells interact with their physical environment. Using advanced microfabrication techniques, he demonstrated that mechanical forces can regulate nuclear structure and function, unveiling a direct link between external physical cues and intracellular signaling. In 2015, he joined Marco Foiani’s lab at IFOM, where he pioneered the use of 3D printing and microfabrication to develop novel mechanobiology tools, including cell stretching and compression devices. Today, as head of the Cancer Engineering R&D Core Facility, he continues to drive innovation at the intersection of physics, engineering, and cancer research, developing technologies that enhance our understanding of tumor biology and its clinical implications.